These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 343210)

  • 41. Babesia bovis: successful vaccination against homologous challenge in splenectomised calves using a fraction of haemagglutinating antigen.
    Goodger BV; Wright IG; Waltisbuhl DJ; Mirre GB
    Int J Parasitol; 1985 Apr; 15(2):175-9. PubMed ID: 3997349
    [No Abstract]   [Full Text] [Related]  

  • 42. A serological survey for Babesia in cattle in Scotland. III. The rates of acquisition and loss of antibody to Babesia and their effects on observed levels of antibody incidence.
    Blewett DA; Adam KM
    Ann Trop Med Parasitol; 1978 Dec; 72(6):513-22. PubMed ID: 736661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum carboxypeptidase B levels during acute and mild Babesia divergens infections of adult cattle.
    Taylor SM; Elliott CT
    Res Vet Sci; 1983 Nov; 35(3):370-1. PubMed ID: 6665323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of dried blood samples as a source of antibody in the micro ELISA test for Babesia divergens.
    Young ER; Purnell RE
    Vet Rec; 1980 Jan; 106(3):60-1. PubMed ID: 6987802
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunity of cattle to Babesia bigemina following its elimination from the host, with observations on antibody levels detected by the indirect fluorescent antibody test.
    Callow LL; McGregor W; Parker RJ; Dalgliesh RJ
    Aust Vet J; 1974 Jan; 50(1):12-5. PubMed ID: 4594670
    [No Abstract]   [Full Text] [Related]  

  • 46. Cell culture-derived Babesia bovis vaccine: sequential challenge exposure of protective immunity during a 6-month postvaccination period.
    Kuttler KL; Levy MG; Ristic M
    Am J Vet Res; 1983 Aug; 44(8):1456-9. PubMed ID: 6354014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation of Babesia divergens from carrier cattle blood using in vitro culture.
    Malandrin L; L'Hostis M; Chauvin A
    Vet Res; 2004; 35(1):131-9. PubMed ID: 15099510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination of older Bos taurus bulls against bovine babesiosis.
    Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
    Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune response to Babesia bigemina infection in pregnant cows.
    García TD; Figueroa MJ; Ramos AJ; Rojas MC; Cantó AG; Falcón NA; Alvarez MJ
    Ann N Y Acad Sci; 2004 Oct; 1026():298-301. PubMed ID: 15604509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative infectivity of Babesia divergens and a zoonotic Babesia divergens-like parasite in cattle.
    Holman PJ; Spencer AM; Telford SR; Goethert HK; Allen AJ; Knowles DP; Goff WL
    Am J Trop Med Hyg; 2005 Nov; 73(5):865-70. PubMed ID: 16282295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and serological response after experimental inoculation with Babesia divergens of newborn calves with and without maternal antibodies.
    Christensson DA
    Acta Vet Scand; 1987; 28(3-4):381-92. PubMed ID: 3454549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A serological survey for Babesia in cattle in Scotland II. The occurrence of antibody in the population and the distribution of infected herds.
    Adam KM; Blewett DA
    Ann Trop Med Parasitol; 1978 Oct; 72(5):417-28. PubMed ID: 363077
    [No Abstract]   [Full Text] [Related]  

  • 53. Babesia divergens vaccine.
    Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The isolation and characterization of a Babesia from red deer (Cervus elaphus).
    Adam KM; Blewett DA; Brocklesby DW; Sharman GA
    Parasitology; 1976 Aug; 73(1):1-11. PubMed ID: 967525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of specific immunoglobulins in antibody-dependent cell-mediated cytotoxicity assays during Babesia bovis infection.
    Goff WL; Wagner GG; Craig TM; Long RF
    Vet Parasitol; 1984 Mar; 14(2):117-28. PubMed ID: 6369760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of schizont and piroplasm antigens of Babesia equi in the indirect fluorescent antibody and complement fixation tests.
    Rehbein G; Heidrich-Joswig S
    Vet Parasitol; 1983 May; 12(2):135-44. PubMed ID: 6351413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Course of infection by Babesia sp. BQ1 (Lintan) and B. divergens in sheep depends on the production of IFNgamma and IL10.
    Guan G; Chauvin A; Yin H; Luo J; Moreau E
    Parasite Immunol; 2010 Feb; 32(2):143-52. PubMed ID: 20070828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroresponse (IgG) after vaccination and natural infection of cattle with Babesia divergens.
    Christensson DA; Morén T
    Acta Vet Scand; 1987; 28(3-4):393-402. PubMed ID: 3454550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of initial Fasciola hepatica infection on the pathogenicity of subsequent Babesia divergens infections in intact and splenectomised calves.
    Hughes DL; Purnell RE; Brockles DW
    Vet Rec; 1977 Apr; 100(15):320-1. PubMed ID: 867747
    [No Abstract]   [Full Text] [Related]  

  • 60. Quinuronium sulphate for the treatment of Babesia divergens infections of splenectomised calves.
    Purnell RE; Lewis D; Young ER
    Vet Rec; 1981 Jun; 108(25):538-9. PubMed ID: 7269188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.